Crossmark

Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s13148-019-0636-y

Published Online: 2019-03-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smith, Adam R.

Smith, Rebecca G.

Pishva, Ehsan

Hannon, Eilis

Roubroeks, Janou A. Y.

Burrage, Joe

Troakes, Claire

Al-Sarraj, Safa

Sloan, Carolyn

Mill, Jonathan

van den Hove, Daniel L.

Lunnon, Katie https://orcid.org/0000-0001-7570-6065
Funding

Funding for this research was provided by:

Alzheimer's Association (NIRG-14-320878)

BRACE

Alzheimer's Society (AS-PG-14-038)

Alzheimer’s Research UK (ARUK-PPG2017B-021, ART-EG2010A-2)

Medical Research Council (MR/N027973/1)

European Union’s Horizon 2020 (643417)
License Information

Text and Data Mining valid from 2019-03-21
More Information

Article History

Received: 15 November 2018

Accepted: 18 February 2019

First Online: 21 March 2019

Ethics approval and consent to participate

: Ethical approval for the study was provided by the NHS South East London REC 3.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.